MEDITRILINE

This brand name is authorized in Nigeria.

Active ingredients

The drug MEDITRILINE contains one active pharmaceutical ingredient (API):

1	Amitriptyline UNII 26LUD4JO9K - AMITRIPTYLINE HYDROCHLORIDE
	Amitriptyline is a tricyclic antidepressant and an analgesic. It prevents the re-uptake, and hence the inactivation of noradrenaline and serotonin at nerve terminals. Reuptake prevention of these monoamine neurotransmitters potentiate their action in the brain. This appears to be associated with the antidepressant activity.
	Read more about Amitriptyline

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-2986	Tablet	Meditriline-50 Tablets TAB 50 mg 1 X 1000	Meditriline-50 Tablets A4-2986 Meditriline AMITRIPTYLINE HYDROCHLORIDE ANTIDEPRESSANT AMITRIPTYLINE HYDROCHLORIDE 50MG TABLETS 1 X 1000 PRESCRIPTION ONLY MEDICINE MANAGEMENT OF DEPRESSION DONY TRIUMPH LTD. NIGERIA MEDO-PHARM INDIA. 01/27/2022 01/26/2027	27/01/2022

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06AA09	Amitriptyline	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AA Non-selective monoamine reuptake inhibitors
Discover more medicines within N06AA09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-2986